NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 20 04:00PM ET
2.32
Dollar change
+0.21
Percentage change
9.95
%
Index- P/E4.68 EPS (ttm)0.50 Insider Own33.81% Shs Outstand157.54M Perf Week-22.41%
Market Cap365.50M Forward P/E- EPS next Y-0.41 Insider Trans-0.30% Shs Float103.99M Perf Month12.62%
Enterprise Value293.76M PEG- EPS next Q-0.06 Inst Own35.39% Short Float18.23% Perf Quarter248.40%
Income41.60M P/S2.48 EPS this Y-124.50% Inst Trans370.14% Short Ratio4.00 Perf Half Y101.74%
Sales147.56M P/B7.47 EPS next Y-337.98% ROA29.38% Short Interest18.96M Perf YTD125.24%
Book/sh0.31 P/C4.58 EPS next 5Y- ROE- 52W Range0.40 - 3.10 Perf Year69.34%
Cash/sh0.51 P/FCF- EPS past 3/5Y- - ROIC149.09% 52W High-25.04% Perf 3Y37.28%
Dividend Est.- EV/EBITDA7.80 Sales past 3/5Y54.69% 19.16% Gross Margin98.86% 52W Low480.00% Perf 5Y-71.14%
Dividend TTM- EV/Sales1.99 EPS Y/Y TTM146.45% Oper. Margin24.37% Volatility9.96% 7.07% Perf 10Y-
Dividend Ex-Date- Quick Ratio1.73 Sales Y/Y TTM23.81% Profit Margin28.19% RSI (14)51.62 Recom1.50
Dividend Gr. 3/5Y- - Current Ratio1.73 EPS Q/Q61.71% SMA20-7.07% Beta2.12 Target Price5.50
Payout0.00% Debt/Eq0.33 Sales Q/Q22.80% SMA5038.90% Rel Volume1.70 Prev Close2.11
Employees121 LT Debt/Eq0.11 EarningsMay 12 BMO SMA200105.20% Avg Volume4.74M Price2.32
IPOOct 08, 2015 Option/ShortYes / Yes EPS/Sales Surpr.116.35% 43.36% Trades Volume8,051,603 Change9.95%
Date Action Analyst Rating Change Price Target Change
May-15-25Upgrade H.C. Wainwright Neutral → Buy $5
Apr-14-25Resumed Piper Sandler Overweight $3.25 → $2.50
May-28-24Upgrade Piper Sandler Neutral → Overweight $2.25 → $3.50
May-09-24Upgrade Wedbush Neutral → Outperform $8
May-06-24Upgrade Jefferies Hold → Buy $2.50 → $8
Apr-22-24Upgrade JP Morgan Underweight → Neutral
Nov-14-22Downgrade BMO Capital Markets Outperform → Market Perform $3 → $2.60
Jul-07-22Downgrade Wedbush Outperform → Neutral $6 → $2
Jul-07-22Downgrade Piper Sandler Overweight → Neutral $10 → $1.50
Jul-07-22Downgrade Mizuho Buy → Neutral $16 → $4
May-29-25 08:00AM
May-19-25 08:00AM
May-13-25 01:58AM
May-12-25 07:25AM
06:50AM
06:22AM Loading…
06:22AM
06:15AM
06:15AM
May-09-25 05:40PM
09:46AM
May-08-25 05:25PM
May-05-25 12:12PM
09:54AM
08:00AM
07:12AM
01:23PM Loading…
May-02-25 01:23PM
Apr-30-25 05:50PM
Apr-29-25 11:59AM
07:51AM
Apr-28-25 04:00PM
09:14AM
09:04AM
Apr-25-25 11:59AM
11:57AM
11:16AM
10:14AM
09:25AM
Apr-24-25 02:20PM
06:31AM
Apr-23-25 09:25AM
07:50AM Loading…
07:50AM
Apr-22-25 10:39AM
Apr-21-25 07:36AM
Apr-16-25 07:32AM
Apr-10-25 07:00AM
Apr-08-25 06:46AM
Apr-04-25 07:29AM
Apr-03-25 10:14AM
Apr-01-25 10:50AM
Mar-28-25 11:20AM
Mar-26-25 07:58AM
02:06AM
Mar-25-25 07:56AM
Mar-21-25 01:03PM
01:01PM
Mar-19-25 01:38PM
Mar-11-25 12:00PM
Mar-07-25 06:45PM
07:41AM
02:18AM
Mar-06-25 05:35PM
04:10PM
Mar-05-25 08:00AM
07:35AM
Feb-27-25 08:00AM
Jan-08-25 08:00AM
Jan-07-25 12:00PM
Jan-06-25 04:05PM
Dec-16-24 09:55AM
Nov-27-24 08:00AM
Nov-19-24 09:35AM
Nov-08-24 11:54AM
02:32AM
Nov-07-24 05:55PM
04:49PM
04:10PM
Nov-06-24 07:52AM
Oct-31-24 08:00AM
Sep-09-24 08:00AM
Sep-04-24 08:00AM
Aug-10-24 08:18AM
Aug-08-24 09:56PM
05:46PM
04:10PM
Aug-01-24 08:00AM
Jul-25-24 02:26AM
Jun-18-24 08:00AM
Jun-17-24 04:15PM
Jun-05-24 06:00AM
Jun-03-24 09:17AM
May-29-24 06:25AM
May-22-24 04:05PM
May-16-24 04:15PM
May-15-24 11:14AM
May-09-24 04:17PM
11:56AM
11:32AM
08:12AM
07:48AM
07:29AM
04:01AM
May-08-24 09:58PM
04:30PM
04:10PM
04:10PM
May-07-24 04:15PM
May-06-24 07:09AM
May-02-24 08:08AM
07:37AM
May-01-24 12:11PM
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ogden ChristopherChief Financial OfficerJun 13 '25Option Exercise0.0037,5000236,885Jun 17 04:11 PM
Ogden ChristopherChief Financial OfficerJun 16 '25Sale2.6910,61428,540226,271Jun 17 04:11 PM
Ogden ChristopherChief Financial OfficerJun 13 '25Sale2.951,6414,841199,385Jun 17 04:11 PM
BELVIN MARCIASVP, Chief Scientific OfficerJun 13 '25Option Exercise0.0037,5000286,136Jun 17 04:10 PM
BELVIN MARCIASVP, Chief Scientific OfficerJun 16 '25Sale2.6913,88437,334272,252Jun 17 04:10 PM
McCarthy Sean A.CEOJun 13 '25Option Exercise0.00150,00001,145,195Jun 17 04:09 PM
McCarthy Sean A.CEOJun 16 '25Sale2.6955,511149,2641,089,684Jun 17 04:09 PM
McCarthy Sean A.CEOMar 18 '25Sale0.6037,65622,556995,195Mar 20 04:34 PM
Ogden ChristopherChief Financial OfficerMar 18 '25Sale0.608,5515,122201,026Mar 20 04:33 PM
Chu Yu-WayeChief Medical OfficerMar 18 '25Sale0.604,0252,411135,725Mar 20 04:32 PM
ROWLAND LLOYD AGeneral CounselMar 18 '25Sale0.6010,2036,112120,594Mar 20 04:32 PM
BELVIN MARCIASVP, Chief Scientific OfficerMar 18 '25Sale0.6019,51211,688248,636Mar 20 04:31 PM
Landau Jeffrey BChief Business OfficerAug 20 '24Option Exercise0.0011,2500123,237Aug 22 06:01 PM
Landau Jeffrey BChief Business OfficerAug 20 '24Sale1.234,1815,139119,056Aug 22 06:01 PM
BELVIN MARCIASVP, Chief Scientific OfficerAug 20 '24Option Exercise0.0011,2500179,829Aug 22 06:01 PM
BELVIN MARCIASVP, Chief Scientific OfficerAug 20 '24Sale1.234,1815,139175,648Aug 22 06:01 PM
ROWLAND LLOYD AGeneral CounselAug 20 '24Option Exercise0.0011,2500134,978Aug 22 06:00 PM
ROWLAND LLOYD AGeneral CounselAug 20 '24Sale1.234,1815,139130,797Aug 22 06:00 PM
Ogden ChristopherChief Financial OfficerAug 20 '24Option Exercise0.006,8750110,061Aug 22 05:59 PM
Ogden ChristopherChief Financial OfficerAug 20 '24Sale1.231,9842,439108,077Aug 22 05:59 PM
McCarthy Sean A.CEOAug 20 '24Option Exercise0.0037,5000671,749Aug 22 05:58 PM
McCarthy Sean A.CEOAug 20 '24Sale1.2313,89817,082657,851Aug 22 05:58 PM